Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.68 EUR | -0.88% | +6.67% | +50.54% |
Apr. 16 | Finland’s Nightingale Health Plots US Expansion | MT |
Apr. 16 | Nightingale Health to Establish A Laboratory in the United States | CI |
Sales 2024 * | 4.7M 5.11M | Sales 2025 * | 8.7M 9.45M | Capitalization | 101M 110M |
---|---|---|---|---|---|
Net income 2024 * | -16M -17.38M | Net income 2025 * | -16M -17.38M | EV / Sales 2024 * | 7.55 x |
Net cash position 2024 * | 65.9M 71.59M | Net cash position 2025 * | 52.2M 56.71M | EV / Sales 2025 * | 5.65 x |
P/E ratio 2024 * |
-6.22
x | P/E ratio 2025 * |
-6.22
x | Employees | 81 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 53.93% |
Latest transcript on Nightingale Health Oyj
1 day | -0.88% | ||
1 week | +6.67% | ||
Current month | -6.15% | ||
1 month | -9.68% | ||
3 months | +52.73% | ||
6 months | +37.70% | ||
Current year | +50.54% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Würtz
FOU | Founder | - | 01-12-31 |
Satu Saksman
FOU | Founder | 48 | 01-12-31 |
Pasi Soininen
FOU | Founder | - | 01-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 59 | 20-12-16 | |
Chairman | 61 | 20-12-31 | |
Olli Pekka Karhi
BRD | Director/Board Member | 61 | 14-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-27 | 1.68 | -0.88% | 58,087 |
24-05-24 | 1.695 | -3.14% | 68,192 |
24-05-23 | 1.75 | +0.57% | 79,975 |
24-05-22 | 1.74 | +6.10% | 81,145 |
24-05-21 | 1.64 | +3.14% | 150,006 |
Delayed Quote Nasdaq Helsinki, May 27, 2024 at 11:24 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+50.54% | 111M | |
+5.91% | 32.95B | |
+18.17% | 8.01B | |
+33.03% | 4.38B | |
-29.52% | 2.67B | |
-13.29% | 1.5B | |
-28.02% | 1.27B | |
-33.09% | 1.2B | |
+11.35% | 996M | |
-38.47% | 864M |
- Stock Market
- Equities
- HEALTH Stock